Both in Pharmaceuticals
Neuphoria Therapeutics vs Bolt Biotherapeutics
Over the past year NEUP returned −29.4% and BOLT returned +29.8%; their daily moves had a correlation of 0.05.
NEUP −29.4% BOLT +29.8%Growth of $1, one year, split-adjusted
| Metric | NEUP | BOLT |
|---|---|---|
| Price | $2.98 | $6.54 |
| Market cap | $16.1M | $15.4M |
| Today | −0.33% | −0.46% |
| 1 month | −13.6% | +86.3% |
| 6 months | −44.6% | +42.5% |
| Year to date | −23.2% | +19.6% |
| 1 year | −32.0% | +17.2% |
| Revenue growth (YoY) | — | −99.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −154400.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.3× |
| Net cash | — | $17.6M |
| Dividend yield | — | — |
| Volatility (60d) | 27.6% | 112.3% |
| Short % of float | 0.1% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).